Published in Blood Weekly, March 17th, 2005
IRG will strive to increase investor awareness of Global Med within the U.S. market by individually and personally introducing Global Med and its management to prequalified investment professionals.
"We are very pleased with Global Med's progress in the domestic and international market place. Our revenues in the third quarter were up 40% from the comparable quarter in 2003. Our business continues to trend higher, as we recently announced that our products are installed at over 300...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.